Rasagiline formulations and processes for their preparation
US7572834B1 · kind B1 · utility
27Cited by
20References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 2006 |
| Grant date | Aug 11, 2009 |
| Priority date | — |
| Expiry date | Dec 5, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C211/42
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject invention provides a pharmaceutical composition comprising N-propargyl-1(R)-aminoindan mesylate; a pharmaceutically acceptable carrier; and greater than 0.7 ppm but less than 30 ppm in total of a compound having the structure:and any salts of the compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.